The Effect of Vaccination with Pfizer-BioNTech or CoronaVac on Disease Prognosis Among Hospitalized COVID-19 Patients
CONCLUSION: Among the inpatients with COVID-19, the predictors for mortality were being unvaccinated, older age, cancer, chronic kidney disease, and cardiovascular diseases. Among the vaccinated inpatients, having two doses of the Pfizer-BioNTech vaccine was the only effective protective measure against mortality, and two doses of the CoronaVac vaccine had no significant effect in preventing fatality.PMID:38633010 | PMC:PMC10985826 | DOI:10.36519/idcm.2023.226
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: Mustafa G üldan Sena Tu ğana Ateş Sebile Sar ıoğlu Sarp Suyabatmaz Pelin İrkören S üda Tekin Mahir Kapmaz Şiran Keske Önder Ergönül Source Type: research
More News: Biotechnology | Cancer | Cancer & Oncology | Cancer Vaccines | Cardiology | Cardiovascular | China Health | Chronic Kidney Disease | Covid Vaccine | COVID-19 | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Hypertension | Intensive Care | Lung Cancer | Pfizer | Study | Turkey Health | Urology & Nephrology | Vaccines